XOFLUZA cpr pel 80 mg 1 pce
7680674260059
CH-67426
J05AX25
08.03.0.
1 / 3
google
Details
- Product number
- 6742603
- CPT
- -
- Packaging group
- 1
- Unit
- Tablette(n)
- Composition
- baloxavirum marboxilum 80 mg, lactosum monohydricum 311.6 mg, carmellosum natricum conexum, povidonum K 25, cellulosum microcristallinum, natrii stearylis fumaras, talcum, Überzug: hypromellosum, talcum, titanii dioxidum, pro compresso obducto corresp. natrium 2.3 mg.
Articles (1)
Xofluza 80 mg, Filmtabletten
Filmtabletten
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
311.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.3 MG | Substance | HBESI |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 67426
- Drug name
- Xofluza, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J05AX25
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/02/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XOFLUZA cpr pel 80 mg 1 pce
- Description (DE)
- XOFLUZA Filmtabl 80 mg 1 Stk
- Market launch
- 30/08/2022
- Narcotic (BTM)
- No